Related Experiment Video
Updated: May 17, 2026

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Chronic mesenteric ischemia: critical review and guidelines for management
Felice Pecoraro1, Zoran Rancic, Mario Lachat
1Clinic for Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland; Vascluar Surgery Unit, University Hospital P. Giaccone, Via L.Giuffrè 5, Palermo, Italy. felicepecoraro@libero.it
Endovascular treatment (ET) offers lower perioperative mortality and morbidity for chronic mesenteric ischemia (CMI) compared to open treatment (OT). However, OT demonstrates superior long-term outcomes, suggesting ET as a potential bridge to surgery.
Area of Science:
- Vascular Surgery
- Gastroenterology
- Interventional Radiology
Background:
- Chronic mesenteric ischemia (CMI) stems from occlusive disease of mesenteric arteries, a rare condition lacking clear treatment guidelines.
- Current treatment options for symptomatic CMI are debated, highlighting the need for evidence-based recommendations.
Purpose of the Study:
- To systematically review and compare the efficacy and safety of endovascular treatment (ET) versus open treatment (OT) for chronic mesenteric ischemia (CMI).
- To analyze treatment outcomes based on historical data to inform clinical decision-making and guideline development.
Main Methods:
- A systematic literature review of studies published over 25 years, focusing on CMI treatments in over 10 patients.
- Comparative analysis of perioperative mortality/morbidity, survival rates, patency, recurrence, technical success, and length of stay between ET and OT groups.
- Subgroup analysis based on publication year (1986-2000 vs. 2001-2010) to assess temporal trends in treatment outcomes.
Main Results:
- Endovascular treatment (ET) showed lower perioperative mortality and morbidity rates compared to open treatment (OT).
- Open treatment (OT) demonstrated superior primary and secondary patency rates, higher revascularization of vessels, and longer follow-up durations.
- Endovascular treatment (ET) had a shorter in-hospital length of stay but a higher CMI recurrence rate; technical success was superior in OT.
Conclusions:
- Endovascular treatment (ET) should be considered the primary option for most CMI patients, particularly those with severe malnutrition, due to lower periprocedural risks.
- Open treatment (OT) is recommended for patients unsuitable for ET or those with a long life expectancy, owing to better long-term results.
- ET may serve as a bridge therapy to OT in select cases requiring reintervention, provided it does not compromise subsequent surgical options.
More Related Videos
04:57Controlled Reversible Visceral Arterial Ischemia, Venous Congestion and Combined Malperfusion via Midline Laparotomy in Rats
Published on: July 5, 2024
07:05Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Angina IV: Management
Acute Coronary Syndrome IV: Interprofessional Care
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peripheral Artery Disease III: Interprofessional Care